GURU.Markets stock price, segment price, and overall market index valuation
The company's share price NanoVibronix Inc.
NanoVibronix produces miniature ultrasound devices for therapeutic use. Its stock price is a bet on the commercial success of its products. The stock price reflects high volatility and dependence on sales news and clinical data.
Share prices of companies in the market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound devices for therapeutic applications, such as pain relief and wound healing. We've categorized it as "Therapeutic Medical Equipment." The chart below shows how the market values โโportable medical technology.
Broad Market Index - GURU.Markets
NanoVibronix is โโa medical device company that produces portable ultrasound devices for pain management and wound healing. It is a component of the GURU.Markets index. The chart below represents the market. See how this stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
NAOV - Daily change in the company's share price NanoVibronix Inc.
NanoVibronix, Inc.'s daily price change reflects volatility in the medical device sector. The metric is sensitive to sales of its ultrasound therapeutic devices, serving as an indicator of commercial success.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound devices for therapeutic applications, such as pain relief. The portable medical equipment segment is competitive. The chart below shows the average volatility in this niche, allowing you to compare NAOV's performance with other innovative companies.
Daily change in the price of a broad market stock, index - GURU.Markets
NanoVibronix produces miniature ultrasound devices for pain treatment and wound healing. The stock price of this medical technology company depends on the adoption of its technology in medical practice. Such unique stories are part of a larger market whose overall volatility you can see.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization NanoVibronix Inc.
NanoVibronix, Inc.'s year-over-year performance is a story of the commercialization of its therapeutic ultrasound devices. Its market capitalization growth over the past 12 months reflects its successful sales of its PainShield and UroShield products. Its valuation is a bet on the widespread application of its noninvasive technology in the treatment of pain and infections.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
NanoVibronix, Inc. is a medical device company that produces portable ultrasound devices for pain management and wound healing. This chart shows how its innovative yet niche technology and market expansion efforts are impacting its volatile performance in the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
NanoVibronix, a manufacturer of portable ultrasound devices for pain relief and wound healing, offers a drug-free alternative to traditional treatments. Its annual market capitalization dynamics demonstrate the growing demand for home medical devices and drug-free therapies.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization NanoVibronix Inc.
NanoVibronix is โโa manufacturer of portable ultrasound therapeutic devices. Its monthly performance reflects progress in the commercialization of its products. News of regulatory approvals and distribution agreements are the main drivers.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
NanoVibronix produces compact therapeutic ultrasound devices for pain management and wound healing. The company's success depends on recognition of its technology and expanding sales. The medical device sector's growth reflects the general trends against which NanoVibronix is โโattempting to commercialize its portable and innovative products.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
NanoVibronix produces portable ultrasound therapeutic devices. As a medical device manufacturer, the company relies on regulatory approval and the ability to establish distribution channels. Its shares can move independently of the market, reacting to news about clinical efficacy and distribution agreements.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization NanoVibronix Inc.
NanoVibronix produces miniature ultrasound devices for pain relief and wound healing. Its weekly stock price performance reflects regulatory approvals, clinical data confirming efficacy, and its ability to bring these products to the consumer market.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound devices for therapeutic applications, such as pain relief. Its business depends on regulatory approvals and successful marketing. The chart below shows how this small medtech company compares to industry giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
NanoVibronix produces compact ultrasound devices for therapy. This is a breakthrough technology, and its shares are highly sensitive to news about its effectiveness and approvals. The chart will show how much its performance is detached from the broader market and is determined by investor confidence in the product.
Market capitalization of the company, segment and market as a whole
NAOV - Market capitalization of the company NanoVibronix Inc.
NanoVibronix's market capitalization chart reflects investor valuations of its ultrasound-based therapeutic devices. Its performance reflects market confidence in its products, such as PainShield and UroShield, for pain relief and infection prevention. Its low valuation reflects the company's challenges in commercializing and gaining widespread acceptance in the medical community.
NAOV - Share of the company's market capitalization NanoVibronix Inc. within the market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for pain management and wound healing. Its market share in the medical device sector is small, but it offers unique solutions. Its market capitalization reflects the potential of its PainShield and UroShield products, which can be used at home.
Market capitalization of the market segment - Therapeutic medical equipment
This graph shows the total market capitalization of the entire therapeutic medical equipment market. For NanoVibronix, with its miniature ultrasound devices, this line is a map of the future. The graph's growth reflects how technology is enabling the creation of increasingly compact and convenient devices for pain management and wound healing at home.
Market capitalization of all companies included in a broad market index - GURU.Markets
NanoVibronix produces miniature ultrasound devices for pain treatment and wound healing. Its market capitalization is determined by its unique therapeutic technology. Overall, this represents the market share of portable and non-invasive medicine.
Book value capitalization of the company, segment and market as a whole
NAOV - Book value capitalization of the company NanoVibronix Inc.
NanoVibronix produces portable ultrasound therapeutic devices. Its book value is derived from its technological and manufacturing assets: technology patents, production lines, and finished product inventory. This is the material foundation for non-invasive treatments. How has this changed? The chart below shows.
NAOV - Share of the company's book capitalization NanoVibronix Inc. within the market segment - Therapeutic medical equipment
NanoVibronix, Inc. manufactures portable ultrasound therapeutic devices. Its business relies on manufacturing facilities where its PainShield and UroShield products are assembled. The chart shows the company's share of the physical infrastructure for manufacturing innovative medical devices.
Market segment balance sheet capitalization - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices. The medical equipment sector, as the chart shows, is capital-intensive. NanoVibronix is โโan innovator, investing in R&D and manufacturing its unique therapeutic devices.
Book value of all companies included in the broad market index - GURU.Markets
NanoVibronix's assets include manufacturing facilities for the creation of compact ultrasound devices for therapeutic applications, such as pain relief or the prevention of catheter-associated infections. Its book value reflects its industrial potential in this medical device niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - NanoVibronix Inc.
NanoVibronix produces miniature therapeutic ultrasound devices. Its market capitalization is based on its patented technology and its potential for treating pain and other conditions. This is a valuation of its medical innovations.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for medical use. The chart shows how investors view its patented technology and its commercial potential in the medical device market, where clinical evidence is required.
Market to book capitalization ratio for the market as a whole
NanoVibronix produces portable ultrasound devices for medical use. This represents a combination of medical technology and consumer electronics. This metric helps assess how the market views companies creating innovative health gadgets and how their valuation compares to the overall market.
Debts of the company, segment and market as a whole
NAOV - Company debts NanoVibronix Inc.
NanoVibronix, a company that produces portable ultrasound therapeutic devices, uses capital to fund manufacturing, clinical trials to expand indications, and marketing. This chart shows the financial needs of a small medical device company on its path to widespread adoption.
Market segment debts - Therapeutic medical equipment
NanoVibronix develops low-intensity ultrasound-based medical devices for pain treatment and wound healing. This chart shows how the commercialization-stage company is funding the marketing and sales of its portable therapeutic devices in an effort to gain acceptance among physicians and patients.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio NanoVibronix Inc.
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. Bringing new medical devices to market requires expenditures on clinical trials, approvals, and marketing. This chart shows how the company uses debt to finance the commercialization of its therapeutic devices.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
NanoVibronix produces compact ultrasound therapeutic devices for pain relief and wound healing. This chart shows how a small medical device company finances its production and marketing. It compares its debt load to the overall medical device market capitalization, reflecting its financial strategy.
Debt to book value of all companies in the market
NanoVibronix produces portable ultrasound devices for pain management and wound healing. The medical device market is competitive and requires significant investment in clinical research and marketing. How dependent is the company on debt to achieve profitability? This chart of total market debt helps evaluate its financial strategy.
P/E of the company, segment and market as a whole
P/E - NanoVibronix Inc.
NanoVibronix produces portable ultrasound devices for therapeutic applications, such as pain relief. This chart shows how investors value its patented technology. The valuation depends on regulatory approvals and successful product launches.
P/E of the market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound therapeutic devices for pain management and wound healing. This chart illustrates the average rating in the therapeutic medical device sector, where clinical evidence of efficacy, patient convenience, and regulatory approval are important factors.
P/E of the market as a whole
NanoVibronix, Inc. produces portable ultrasound therapeutic devices for pain management and wound healing. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether NAOV's valuation reflects confidence in its non-invasive products or whether it is moving in line with overall trends in the healthcare and consumer medicine industries.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company NanoVibronix Inc.
NanoVibronix produces portable ultrasound devices for therapeutic applications, such as pain relief and wound healing. The company's future depends on the acceptance of its technology by the medical community. This chart reflects market expectations regarding the commercial potential of these compact medical devices and their future sales.
Future (projected) P/E of the market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. The company aims to make the therapy accessible for home use. The chart compares NanoVibronix's future profitability expectations with the industry, helping to assess the market's perception of the commercial potential of its medical devices.
Future (projected) P/E of the market as a whole
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. It's a non-invasive medical technology. This chart of overall healthcare sentiment helps understand how investors view the market outlook for portable therapeutic devices that patients can use at home.
Profit of the company, segment and market as a whole
Company profit NanoVibronix Inc.
NanoVibronix, Inc. manufactures compact ultrasound therapeutic devices for pain management and wound healing. Revenue depends on sales of these portable medical devices. This chart shows the company's success in commercializing its patented technology for drug-free pain relief.
Profit of companies in the market segment - Therapeutic medical equipment
NanoVibronix, Inc. manufactures medical devices that use low-frequency ultrasound for pain treatment and wound healing. Its products, such as PainShield, offer a drug-free alternative. This chart shows the overall profitability of the therapeutic medical device sector, where demand for safe and effective home-use solutions is growing.
Overall market profit
NanoVibronix, Inc. produces medical devices that use ultrasound for pain management and wound healing. Demand for its products is driven by their clinical effectiveness and acceptance by the medical community. This market is not dependent on the economic cycles shown in the chart, as the need for pain relief and treatment is constant.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company NanoVibronix Inc.
NanoVibronix produces compact ultrasound therapeutic devices for pain management and wound healing. Future revenue depends on the adoption of its technology by patients and physicians, as well as reimbursement from insurance companies. This chart reflects analyst expectations regarding the commercial potential of its portable medical devices.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. Its products, such as PainShield and UroShield, offer drug-free therapies that can be used at home. This chart shows revenue expectations for the therapeutic medical device sector, helping to evaluate NanoVibronix's innovative solutions.
Future (predicted) profit of the market as a whole
NanoVibronix, Inc. produces medical devices that use ultrasound for pain management and wound healing. The company's success depends on the commercialization and acceptance of its products by the medical community. This economic outlook impacts the overall solvency of the healthcare system and patient willingness to pay for new devices.
P/S of the company, segment and market as a whole
P/S - NanoVibronix Inc.
NanoVibronix produces compact ultrasound therapeutic devices for pain relief and wound healing. Revenue growth reflects the acceptance of its products by patients and physicians. This chart shows how investors view its patented technology and its potential in the medical device market.
P/S market segment - Therapeutic medical equipment
NanoVibronix develops medical devices that use low-frequency ultrasound waves to treat pain and promote wound healing. Their portable products, such as PainShield and UroShield, offer a drug-free alternative for patients. This chart shows the average revenue estimate for the sector, helping to assess how the market views this innovative therapeutic technology.
P/S of the market as a whole
NanoVibronix produces compact ultrasound devices for pain treatment and wound healing. This chart, showing the average market revenue estimate, helps understand how investors value this innovative but niche medical device company compared to major players in the healthcare sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company NanoVibronix Inc.
NanoVibronix produces portable ultrasound devices for pain management and wound healing. For a medical device company, future revenue estimates are important. They reflect investor expectations for sales growth of its products, such as UroShield and PainShield, and their acceptance by both patients and the medical community as drug-free treatments.
Future (projected) P/S of the market segment - Therapeutic medical equipment
NanoVibronix develops ultrasound-based medical devices, including those for pain relief and infection prevention. This chart compares the company's estimated future sales with expectations for the medical device sector. It shows whether investors believe in the therapeutic efficacy and commercial potential of its compact ultrasound devices.
Future (projected) P/S of the market as a whole
NanoVibronix develops medical devices that use low-frequency ultrasound for pain relief and wound healing. The company's success depends on the acceptance of its technology by doctors and patients. This graph of investor expectations reflects their belief that new non-invasive therapeutic methods will find acceptance in the healthcare market.
Sales of the company, segment and market as a whole
Company sales NanoVibronix Inc.
The graph illustrates NanoVibronix's revenue from sales of its portable ultrasound therapeutic devices, such as PainShield and UroShield, for pain relief and infection prevention. Revenue growth depends on the expansion of its distribution network and the adoption of its technology by both patients and physicians.
Sales of companies in the market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound devices for pain treatment and wound healing. Its sales structure shows the proportion of revenue generated by its core products, such as PainShield and UroShield. This reflects its focus on non-drug treatments across various therapeutic areas.
Overall market sales
NanoVibronix, Inc. manufactures medical devices that use ultrasound for pain management and wound healing. The company offers non-drug therapeutic solutions. While the overall economic outlook impacts consumer healthcare spending, NanoVibronix's primary driver is the search for effective and safe alternatives to traditional treatments.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company NanoVibronix Inc.
NanoVibronix develops medical devices that use low-frequency ultrasound for pain treatment and wound healing. Sales growth depends on the acceptance of its products, such as PainShield and UroShield, by the medical community and patients. This chart shows analyst expectations for the commercialization of its therapeutic ultrasound technology.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for pain relief and wound healing. This chart shows the forecast for the therapeutic medical equipment market. Is demand for non-invasive, wearable medical devices for home use growing? This reflects overall consumer trends in healthcare.
Future (projected) sales of the market as a whole
NanoVibronix produces compact ultrasound therapeutic devices for pain relief and wound healing. Demand for these medical devices depends on their effectiveness, physician recommendations, and consumer willingness to pay. This general economic activity pattern influences discretionary health spending, particularly on items not covered by insurance.
Marginality of the company, segment and market as a whole
Company marginality NanoVibronix Inc.
NanoVibronix produces compact ultrasound therapeutic devices for pain management and wound healing. This chart shows the company's success in commercializing its patented technology. Profitability depends on sales of its portable devices, regulatory approvals, and convincing the medical community of the effectiveness of its non-invasive approach.
Market segment marginality - Therapeutic medical equipment
NanoVibronix, Inc. produces ultrasound-based medical devices for pain treatment and wound healing. The company's profitability depends on sales of its portable devices, regulatory approvals, and acceptance of its technology by the medical community. This metric reflects its path to commercial success.
Market marginality as a whole
NanoVibronix produces portable ultrasound devices for pain management and wound healing. Its success depends on the adoption of its technology by doctors and patients. This gross margin chart reflects the state of the healthcare system and consumer spending on medical devices, which shape the company's market environment.
Employees in the company, segment and market as a whole
Number of employees in the company NanoVibronix Inc.
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. Its small staff is focused on the production and commercialization of these innovative products. This chart shows how the company manages its resources to promote its PainShield and UroShield devices in the medical market.
Share of the company's employees NanoVibronix Inc. within the market segment - Therapeutic medical equipment
NanoVibronix produces compact ultrasound therapeutic devices for pain management and wound healing. The development and production of these medical devices require electronic engineers, while their sales require marketing teams. This chart shows the company's market share, reflecting its production and commercial scale in the portable medical device niche.
Number of employees in the market segment - Therapeutic medical equipment
NanoVibronix produces portable ultrasound devices for pain treatment and wound healing. The chart below reflects employment in the therapeutic medical equipment sector. The company's compact and easy-to-use products, such as PainShield and UroShield, allow for at-home therapy.
Number of employees in the market as a whole
NanoVibronix produces portable ultrasound devices for therapeutic use. The company's growth depends on the market acceptance of its medical devices. This chart shows overall employment, and NanoVibronix is โโan example of a MedTech company, where job creation is driven by the development and commercialization of innovative products to improve health.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company NanoVibronix Inc. (NAOV)
NanoVibronix produces medical devices using low-intensity ultrasound (e.g., UroShield, PainShield). It's an R&D-driven medtech company. This chart shows how the market values โโtheir technology. It reflects the market value per employee, which is a measure of the value of their patents and the commercial potential of their devices.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
NanoVibronix (NAOV) produces medical devices that use ultrasound for pain management and wound healing. In the therapeutic equipment industry, this characteristic reflects the uniqueness and effectiveness of the technology. A high employee rating may indicate that their portable devices offer patients a convenient, drug-free treatment option for chronic conditions.
Market capitalization per employee (in thousands of dollars) for the overall market
NanoVibronix produces portable ultrasound devices for pain management and wound healing. In the medical device sector, this metric reflects the technology's value. The market sees the potential of its compact and easy-to-use products to transform approaches to treating chronic pain and other conditions at home.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company NanoVibronix Inc. (NAOV)
NanoVibronix is โโa company that produces medical devices that use ultrasound for pain treatment and wound healing (UroShield, PainShield). This includes R&D and commercialization of medical equipment. This chart shows how successfully the company sells its niche devices. Revenue per employee is the margin earned on each device sold.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
NanoVibronix, Inc. manufactures portable ultrasound therapeutic devices. In the field of home medical devices, productivity per employee depends on the balance between R&D, manufacturing, and marketing. The graph shows how successfully the company commercializes its innovative products and how this compares to other manufacturers.
Profit per employee (in thousands of dollars) for the market as a whole
NanoVibronix produces medical devices using low-frequency ultrasound. Their products (PainShield, UroShield) are designed to relieve pain and prevent infections. It's a medical technology company. This chart helps illustrate how profitable a business based on proprietary medical technology and manufacturing is per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee NanoVibronix Inc. (NAOV)
NanoVibronix produces compact ultrasound therapeutic devices. This chart demonstrates the commercial success of their innovative products. The growth in revenue per employee indicates that their pain relief and wound healing devices are finding their customers and are successfully selling through various channels.
Sales per employee in the market segment - Therapeutic medical equipment
NanoVibronix (NAOV) is a medical technology company that produces portable ultrasound devices for therapeutic purposes (e.g., UroShield for catheters, PainShield). This chart shows the average output in the sector. For NAOV, this is an indicator of how productive their R&D and sales teams are in promoting these niche medical devices.
Sales per employee for the market as a whole
NanoVibronix produces medical devices that use low-intensity ultrasound for pain relief (UroShield, PainShield). It is a medical hardware business. This indicator demonstrates the effectiveness of their R&D, manufacturing, and sales in commercializing this non-invasive technology.
Short shares by company, segment and market as a whole
Shares shorted by company NanoVibronix Inc. (NAOV)
NanoVibronix (NAOV) produces portable ultrasound devices for pain management and wound healing. This chart shows the number of short positions. Short positions may reflect concerns about the clinical effectiveness of these devices or the company's ability to convince doctors and insurance companies of their necessity.
Shares shorted by market segment - Therapeutic medical equipment
NanoVibronix (NAOV) produces medical devices that use low-intensity ultrasound for pain relief (UroShield, PainShield). This chart shows the overall short position in the medical device sector, highlighting investor concerns about insurance reimbursement issues.
Shares shorted by the overall market
NanoVibronix produces portable ultrasound devices (for pain relief and wound healing). This chart illustrates the overall market pessimism. Investors fear that during a crisis, this product (not considered an urgent need) will be poorly covered by insurance, and consumers will be reluctant to spend money on it.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator NanoVibronix Inc. (NAOV)
NanoVibronix produces compact ultrasound devices for pain relief and healing. These are portable medical devices. This indicator measures the "temperature" of market acceptance. It "warms up" on news of approvals (FDA, CE) or distributor contracts and "cools down" in anticipation of sales growth.
RSI 14 Market Segment - Therapeutic medical equipment
NanoVibronix (NAOV) is a company that creates ultrasound-based medical devices. Their products (PainShield, UroShield) are designed to relieve pain and prevent infections. This chart tracks the pulse of the Therapeutic Equipment sector. It helps differentiate NAOV's technology from the overall "overheated" or "oversold" medtech industry.
RSI 14 for the overall market
For NanoVibronix (NAOV), an R&D company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the cash spigot is turned off, and cash-burning companies risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NAOV (NanoVibronix Inc.)
NanoVibronix produces compact therapeutic ultrasound devices (PainShield, UroShield) used at home to relieve pain and prevent infections. This chart shows the average price target from analysts, reflecting their expectations for sales growth and expanded insurance coverage for these medical devices.
The difference between the consensus estimate and the actual stock price NAOV (NanoVibronix Inc.)
NanoVibronix is โโa medical technology company that has "shrinked" ultrasound. It produces portable devices (PainShield) for non-invasive pain and wound treatment. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their belief in the technology's adoption.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
NanoVibronix (NAOV) is a medical company that has developed "therapeutic ultrasound" in the form of a patch (UroShield, PainShield) for the treatment of pain and infections. This chart shows general expectations for the therapeutic medical device sector, reflecting experts' confidence in this "at-home ultrasound" technology.
Analysts' consensus forecast for the overall market share price
NanoVibronix is โโa medical device company that produces portable ultrasound devices (PainShield, UroShield) used to treat pain and prevent catheter infections. This chart shows overall market sentiment. For NanoVibronix, as a company in the commercialization stage, general optimism is important for funding, but their growth depends more on acceptance by physicians and insurers.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index NanoVibronix Inc.
NanoVibronix is โโa MedTech patch. Their specialty is therapeutic ultrasound: they produce portable devices (PainShield, UroShield) that use ultrasound (rather than drugs) to relieve pain or prevent infections (catheters). This chart summarizes their adoption history. It reflects their (minuscule) sales and their (very difficult) path to insurance reimbursement.
AKIMA Market Segment Index - Therapeutic medical equipment
NanoVibronix (NAOV) is ultrasound in a patch. The company produces miniature wearable devices (PainShield, UroShield) that generate therapeutic ultrasound for pain relief and the prevention of urinary tract infections. This chart shows the average index for the segment, helping investors assess the success of this wearable technology.
The AKIM Index for the overall market
NanoVibronix is โโa manufacturer of medical devices that use surface acoustic waves (SAW) to prevent catheter infections and treat pain. This chart, which reflects the market average, is just a backdrop. It helps assess how NanoVibronix, a niche MedTech company, stacks up against overall macroeconomic trends.